FDA grants meeting on Avastin for breast cancer

February 24, 2011 4:46:06 PM PST
The Food and Drug Administration has granted Swiss drugmaker Roche a first-of-a-kind public hearing to defend the effectiveness of its drug Avastin for treating breast cancer, just months after the agency ruled that the drug is ineffective for that use.

Load Comments